Workflow
创新农药中间体
icon
Search documents
雅本化学2025年上半年业绩改善 研发投入与医药业务潜力凸显
Quan Jing Wang· 2025-08-27 00:44
Core Viewpoint - Yabao Chemical (300261) has shown significant improvement in its operational performance in the first half of 2025, with revenue reaching 662 million yuan, a year-on-year increase of 12.3%, and a narrowed net loss of 8.67 million yuan, down 83% from the previous year, primarily driven by the recovery of its pesticide intermediate business and effective cost control measures [1][2]. Group 1: Financial Performance - The company achieved a revenue of 662 million yuan in the first half of 2025, reflecting a 12.3% year-on-year growth [1]. - The net loss attributable to shareholders was 8.67 million yuan, which represents an 83% reduction compared to the same period last year [1]. Group 2: Business Recovery and Strategy - The pesticide segment has shown a significant recovery, with a substantial increase in orders quarter-on-quarter, attributed to strategic investments made over the past two to three years [1]. - The company has established deep collaborations with major agricultural enterprises such as Corteva, Bayer, and FMC, leading to the successful implementation of innovative pesticide intermediates and active ingredients [1]. Group 3: Pharmaceutical Business Development - Yabao Chemical has made notable progress in its pharmaceutical business by forming a strategic partnership with leading domestic innovative drug company Heng Rui Medicine (600276), focusing on areas such as oncology, metabolism, and cardiovascular diseases [1]. - This collaboration is expected to enhance Yabao Chemical's competitiveness in the pharmaceutical industry and expand its market presence in pharmaceutical intermediates and active pharmaceutical ingredients [1]. Group 4: R&D Investment - The company increased its R&D expenditure to 58.19 million yuan in the first half of 2025, marking a 49.46% year-on-year increase [2]. - Yabao Chemical emphasizes long-term commitment to R&D innovation, effectively applying green technologies such as continuous flow technology and biocatalysis in its pesticide and pharmaceutical CDMO businesses [2]. Group 5: Future Outlook - With ongoing increases in R&D investment, continuous capacity release in the pesticide business, and expansion in the pharmaceutical sector, Yabao Chemical is positioned to achieve sustainable growth and stand out in a competitive market [2].